---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-006578"
form_type: "8-K"
ticker: "KALA"
cik: "0001479419"
company_name: "KALA BIO, Inc."
filed_at: "2023-04-25T23:59:59+00:00"
generated_at: "2026-06-16T16:07:38.046261+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Kala Pharmaceuticals stockholders approve option exchange and auditor ratification at special meeting

## Summary
- Option exchange proposal approved: 385,429 for, 57,585 against, 525,624 broker non-votes.
- Ratification of Deloitte & Touche as auditor for FY2023 approved: 937,505 for, 23,974 against.
- Adjournment proposal approved: 873,292 for, 94,743 against.

## SEC filing metadata
- accession: 0001558370-23-006578
- form_type: 8-K
- ticker: KALA
- cik: 0001479419
- company_name: KALA BIO, Inc.
- filed_at: 2023-04-25T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1479419/000155837023006578/0001558370-23-006578-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1479419/000155837023006578/kala-20230424x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-006578
- JSON: https://secwatch.observer/filing/0001558370-23-006578.json
- Plain text: https://secwatch.observer/filing/0001558370-23-006578.txt

## Key facts
- Shareholder Votes
  KALA BIO, Inc. shareholders approved Ratification of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-04-24 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-04-24
  source text: 2. The Company’s stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 (the “Auditor Ratification Proposal”). The results of the stockholders’ vote with respect to such ratification were as follows: ​ Votes For Votes Against Votes Abstaining Broker Non- Votes 937,505 ​ 23,974 ​ 11,739 ​ 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1479419/000155837023006578/0001558370-23-006578-index.htm
- Shareholder Votes
  KALA BIO, Inc. shareholders approved Adjournment of Special Meeting to permit further solicitation if necessary at the 2023-04-24 meeting.
  - Outcome: passed
  - Meeting: 2023-04-24
  source text: 3. The Company’s stockholders approved a proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Option Exchange Proposal and the Auditor Ratification Proposal. The results of the stockholders’ vote with respect to such adjournment proposal were as follows: ​ Votes For Votes Against Votes Abstaining Broker Non- Votes 873,292 ​ 94,743 ​ 5,183 ​ 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1479419/000155837023006578/0001558370-23-006578-index.htm
- Shareholder Votes
  KALA BIO, Inc. shareholders approved One-time exchange of stock options for newly issued restricted stock units (Option Exchange Proposal) at the 2023-04-24 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2023-04-24
  source text: 1. The Company’s stockholders approved the one-time exchange of stock options issued under the Company’s 2009 Employee, Director and Consultant Equity Incentive Plan, the Company’s 2017 Equity Incentive Plan, and inducement awards granted to certain newly hired employees in accordance with Nasdaq Listing Rule 5635(c)(4) that are held by executive officers, other employees, and non-employee directors of the Company for newly issued restricted stock units (the “Option Exchange Proposal”). The results of the stockholders’ vote with respect to the Option Exchange Proposal were as follows: ​ Votes For Votes Against Votes Abstaining Broker Non- Votes 385,429 ​ 57,585 ​ 4,580 ​ 525,624
  evidence_url: https://www.sec.gov/Archives/edgar/data/1479419/000155837023006578/0001558370-23-006578-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.